Immunocore Holdings annual free cash flow
2021
2022
2023
2024
2025
Immunocore Holdings Free Cash Flow (FCF) History (IMCR)
Immunocore Holdings reported −$15.1M in free cash flow for fiscal 2025, a decrease of $35.9M from the previous fiscal year, with a free cash flow margin of −3.76%.
View full Immunocore Holdings company overviewImmunocore Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$15.1M | −$35.9M | — | −3.76% |
| 2024 | 2024-12-31 | $20.9M | $23.4M | — | +6.73% |
| 2023 | 2023-12-31 | −$2.5M | $48.9M | — | −1.00% |
| 2022 | 2022-12-31 | −$51.4M | $93.1M | — | −29.49% |
| 2021 | 2021-12-31 | −$144.5M | — | — | −3543.21% |
Immunocore Holdings quarterly free cash flow
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.1M | −$10.4M | −40.74% | +13.06% |
| Q1 2026 | 2026-03-31 | −$15.6M | −$15.7M | — | −14.58% |
| Q4 2025 | 2025-12-31 | −$35.5M | −$18.0M | — | −34.01% |
| Q3 2025 | 2025-09-30 | −$5.2M | −$25.5M | — | −5.02% |
| Q2 2025 | 2025-06-30 | $25.6M | $2.4M | +10.41% | +26.08% |
| Q1 2025 | 2025-03-31 | $137,000 | $5.2M | — | +0.15% |
| Q4 2024 | 2024-12-31 | −$17.5M | $1.0M | — | −20.86% |
| Q3 2024 | 2024-09-30 | $20.3M | $10.4M | +105.52% | +25.30% |
| Q2 2024 | 2024-06-30 | $23.1M | $24.5M | — | +30.69% |
| Q1 2024 | 2024-03-31 | −$5.0M | −$12.6M | — | −7.12% |
| Q4 2023 | 2023-12-31 | −$18.6M | — | — | −26.44% |
| Q3 2023 | 2023-09-30 | $9.9M | — | — | +15.23% |
| Q2 2023 | 2023-06-30 | −$1.4M | — | — | −2.26% |
| Q1 2023 | 2023-03-31 | $7.5M | — | — | +13.79% |
Immunocore Holdings free cash flow growth trends
Immunocore Holdings's latest reported quarter, Q2 2026, generated $15.1M in free cash flow, a decrease of 40.74% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Immunocore Holdings filings at SEC.gov ↗